Table 2. The pathological characteristics of the patients.
| Group | Case # | Separate | Tumor Size (cm) | AD pattern | SCC Differentiation | Node | Invol of Bronch | Invol of Pleura | LVI | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AD | SCLC | SCC | |||||||||
| 1 | 1–1 | Y | 5 | 1.5 | Acinar | - | - | - | - | - | |
| 1–2 | Y | 2.3 | NA | - | Acinar | - | - | - | - | - | |
| 2 | 2–1 | Y | 1.5 | 3.5 | - | Micropap | - | Y | N | N | Y |
| 2–2 | Y | 1.8 | 1.8 | - | Lepidic | - | - | - | N | Y | |
| 2–3 | N | 3.5, 30% | 70% | - | Acinar | - | Y | N | Y | Y | |
| 2–4 | N | NA | NA | - | Acinar | - | - | - | - | - | |
| 3 | 3–1 | Y | - | 0.7 | 2.8 | - | Poor | - | - | Y | N |
| 3–2 | Y | - | 1.2 | 5 | - | Moderate | Y | Y | Y | Y | |
| 3–3 | Y | - | 3.5 | 2.9 | - | Well | - | - | - | - | |
| 3–4 | N | - | 6 20% | 80% | - | Well | N | Y | N | Y | |
| 3–5 | N | - | NA | NA | - | Moderate | - | - | - | - | |
| 4 | 4–1 | N | 2.6 2.5% | 2.5% | 95% | Solid | Poor | - | - | N | N |
| 4–2 | Y | 5%* | 2.1 | 4.5 95% | Acinar | Well | N | Y | Y | Y | |
AD: adenocarcinoma; SCLC: small cell lung cancer; SCC: squamous cell carcinoma; Invol of Bronch: involvement of the bronchus; Invol of Pleura: involvement of the pleura; LVI: lymphovascular invasion; Y: yes; N: no; NA: not available; Micropap: micropapillary.
*
The AD component is mixed with SCC component.